Nasdaq · CIK 0002032341
CYAB CYABRA, INC.
Insider trading from SEC Form 4. Last filing May 18, 2026.
CYABRA, INC. (CYAB) has 17 SEC Form 4 filings on file from 10 insiders, the latest filed on May 18, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at CYABRA, INC., scored.
Transactions
Every row filed, 25 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | Sonny Vu director | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 107,329 | May 18, 2026 |
| May 14, 2026 | Michael P Madon director | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 100,000 | May 18, 2026 |
| May 14, 2026 | Ido Shraga Chief Technology Officer | AGrant or award Common Stock | +130,000 | $0.00 | $0 | 840,549 | May 18, 2026 |
| May 14, 2026 | Emmanuel Heymann Chief Revenue Officer | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 100,000 | May 18, 2026 |
| May 14, 2026 | Yossef Daar Chief Product Officer | AGrant or award Common Stock | +130,000 | $0.00 | $0 | 840,549 | May 18, 2026 |
| May 14, 2026 | James Francis Flanagan director | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 110,000 | May 18, 2026 |
| May 14, 2026 | Yael Sandler Chief Financial Officer | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 40,000 | May 18, 2026 |
| May 14, 2026 | Dan Brahmy Chief Executive Officer | AGrant or award Common Stock | +130,000 | $0.00 | $0 | 799,402 | May 18, 2026 |
| Mar 27, 2026 | Michael P Madon director | AGrant or award Stock Option(Right to Buy)derivative | +14,436 | - | - | 14,436 | Mar 31, 2026 |
| Mar 27, 2026 | Ido Shraga Chief Technology Officer | AGrant or award Common Stockindirect: See footnote | +577,549 | - | - | 577,549 | Mar 31, 2026 |
| Mar 27, 2026 | Yossef Daar Chief Product Officer | AGrant or award Common Stockindirect: See footnote | +577,549 | - | - | 577,549 | Mar 31, 2026 |
| Mar 27, 2026 | Sonny Vu director | AGrant or award Common Stock | +27,329 | - | - | 27,329 | Mar 31, 2026 |
| Mar 27, 2026 | Emmanuel Heymann Chief Revenue Officer | AGrant or award Stock Option(Right to Buy)derivative | +25,264 | - | - | 25,264 | Mar 31, 2026 |
| Mar 27, 2026 | Yael Sandler Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +101,071 | - | - | 101,071 | Mar 31, 2026 |
| Mar 27, 2026 | Josette Sheeran director | AGrant or award Stock Option (Right to Buy)derivative | +144,387 | - | - | 144,387 | Mar 31, 2026 |
| Mar 27, 2026 | Michael Pompeo director | AGrant or award Stock Option(Right to Buy)derivative | +101,072 | - | - | 101,072 | Mar 31, 2026 |
| Mar 27, 2026 | Dan Brahmy Chief Executive Officer | AGrant or award Common Stockindirect: See footnote | +535,402 | - | - | 535,402 | Mar 31, 2026 |
| Mar 27, 2026 | Emmanuel Heymann Chief Revenue Officer | AGrant or award Stock Option(Right to Buy)derivative | +28,883 | - | - | 28,883 | Mar 31, 2026 |
| Mar 27, 2026 | Sonny Vu director | AGrant or award Common Stockindirect: See footnote | +273,278 | - | - | 273,278 | Mar 31, 2026 |
| Mar 27, 2026 | Dan Brahmy Chief Executive Officer | AGrant or award Common Stockindirect: See footnote | +134,000 | $0.00 | $0 | 669,402 | Mar 31, 2026 |
| Mar 27, 2026 | Yossef Daar Chief Product Officer | AGrant or award Common Stockindirect: See footnote | +133,000 | $0.00 | $0 | 710,549 | Mar 31, 2026 |
| Mar 27, 2026 | Ido Shraga Chief Technology Officer | AGrant or award Common Stockindirect: See footnote | +133,000 | $0.00 | $0 | 710,549 | Mar 31, 2026 |
| Mar 27, 2026 | Dan Brahmy Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +42,146 | - | - | 42,146 | Mar 31, 2026 |
| Mar 27, 2026 | Sonny Vu director | AGrant or award Stock Option (Right to Buy)derivative | +18,048 | - | - | 18,048 | Mar 31, 2026 |
| Mar 27, 2026 | Sonny Vu director | AGrant or award Stock Option (Right to Buy)derivativeindirect: See footnote | +12,013 | - | - | 12,013 | Mar 31, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Dan BrahmyChief Executive Officer
- Yossef DaarChief Product Officer
- James Francis Flanagandirector
- Emmanuel HeymannChief Revenue Officer
- Michael P Madondirector
- Michael Pompeodirector
- Yael SandlerChief Financial Officer
- Josette Sheerandirector
- Ido ShragaChief Technology Officer
- Sonny Vudirector
Questions about CYAB
Answered from the filings on this page, as of the latest one.
Are insiders buying CYAB?
No. In the last 90 days no insider at CYABRA, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CYAB on the open market?
No open-market trade has been scored at CYABRA, INC.. The latest Form 4 on file was filed on May 18, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at CYABRA, INC.?
10 people have filed a Form 4 at CYABRA, INC., among them Dan Brahmy (Chief Executive Officer), Yossef Daar (Chief Product Officer), James Francis Flanagan (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.